Services
Growth Innovation Operations
Cases
Insights
AGP Insights Eco Insiders Podcast
About
Contact
EN
中文

Personal Information

Miguel Angel Esteban
miguel@gibh.ac.cn
English, Chinese, Spanish
Guangdong

Academic Information

University of Chinese Academy of Sciences
Medical School
  • 1999-09 to 2003-06 PhD: Autonomous University of Madrid
  • 1988-09 to 1994-06 Bachelor's: University of Navarra
  • 1991-1992 - University of Navarra, Department of Pathology - Research Assistant
  • 1992-1993 - University of Navarra, Department of Microbiology - Research Assistant
  • 1995-1998 - Princess Hospital (Madrid), Emergency Department - Rotating Doctor
  • 2003-2007 - Imperial College London, Faculty of Medicine, Renal Laboratory - Associate Researcher
  • 2008 to present - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, South China Institute for Stem Cell Biology and Regenerative Medicine - Chief Researcher
  • 2011: Friendship Award of Yangcheng
  • 2011: Foreign Expert of Chinese Academy of Sciences
  • 2012: Foreign Expert of Chinese Academy of Sciences
  • 2012: Zhu Li Yuehua Excellent Teacher Award of Chinese Academy of Sciences
  • 2012: Excellent Graduate Supervisor of Guangzhou Education Base
  • 2015: Distinguished Researcher of Chinese Academy of Sciences
  • 2017: Outstanding Scientific Achievement Award of Chinese Academy of Sciences (Outstanding Contributor)
  • 2018: Honorary Citizen of Guangzhou
  • 2018: Innovation Award of Chinese Society for Stem Cell Research
  • 2018: Star of Innovation Talent of Guangzhou Huangpu Development Zone
  • 2019: China Government Friendship Award
  • 2020: First Prize of Natural Science of Guangdong Province
  • 2021: Nanyue Innovation Award of Guangdong Province

Research

Stem Cells
Neurodegenerative Diseases
Reprogramming
Transdifferentiation
Non-coding RNA
Induced Pluripotent Stem Cells
Cell Fate Regulation
  • Capture of the newly transcribed RNA interactome using click chemistry, Miguel Angel Esteban, 2021
  • Global Profiling of the Lysine Crotonylome in Different Pluripotent States, Miguel Angel Esteban, 2021
  • beta-Catenin safeguards the ground state of mouse pluripotency by strengthening the robustness of the transcriptional apparatus, Miguel Angel Esteban, 2020
  • JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency, Miguel Angel Esteban, 2020
  • Generation of induced pluripotent stem cell line (ZZUi011-A) from urine sample of a normal human, Miguel Angel Esteban, 2018
  • Ncor/smrt co-repressors cooperate with c-myc to create an epigenetic barrier to somatic cell reprogramming, Miguel Angel Esteban, 2018
  • Capturing the interactome of newly transcribed RNA, Miguel Angel Esteban, 2018
  • Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1, Miguel Angel Esteban, 2017
  • Generation of Human Liver Chimeric Mice with Hepatocytes from Familial Hypercholesterolemia Induced Pluripotent Stem Cells, Miguel Angel Esteban, 2017
  • Transcriptional Control of Somatic Cell Reprogramming, Miguel Angel Esteban, 2016
  • LncRNA Dum interacts with Dnmts to regulate Dppa2 expression during myogenic differentiation and muscle regeneration, Miguel Angel Esteban, 2015
  • Characterization of a novel cell penetrating peptide derived from human Oct4, Miguel Angel Esteban, 2014
  • Solving the puzzle of Parkinson's disease using induced pluripotent stem cells, Miguel Angel Esteban, 2014
  • Generation of knockout rabbits using transcription activator-like effector nucleases, Miguel Angel Esteban, 2014
  • Transcriptional Pause Release Is a Rate-Limiting Step for Somatic Cell Reprogramming, Miguel Angel Esteban, 2014
  • Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C, Miguel Angel Esteban, 2011
  • MicroRNA Cluster 302-367 Enhances Somatic Cell Reprogramming by Accelerating a Mesenchymal-to-Epithelial Transition, Miguel Angel Esteban, 2011
  • Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases, Miguel Angel Esteban, 2010
  • Porcine induced pluripotent stem cell may bridge the gap between mouse and human ips, Miguel Angel Esteban, 2010
  • A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts, Miguel Angel Esteban, 2010
  • Induced pluripotent stem cell can be used to model the genomic imprinting disorder prader-willi syndrome, Miguel Angel Esteban, 2010
  • Vitamin C enhances the generation of mouse and human induced pluripotent stem cell, Miguel Angel Esteban, 2010
  • VHL Inactivation Induces HEF1 and Aurora Kinase A, Miguel Angel Esteban, 2010
  • Generation of human induced pluripotent stem cell from umbilical cord matrix and amniotic membrane mesenchymal cells, Miguel Angel Esteban, 2010
  • The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters, Miguel Angel Esteban, 2010
Keywords
Stem Cells Neurodegenerative Diseases Reprogramming Transdifferentiation Non-Coding Rna Induced Pluripotent Stem Cells Cell Fate Regulation Pluripotency Epigenetics Gene Therapy
Related Professors
Wei Wei - Wuhan University
Area of Focus
Neuroscience | Epigenetics | Non-Coding Rna | Dna | Histone Modifications | Learning | Memory | Anxiety | Ptsd | Pathogenesis
Shuliang Chen - Wuhan University
Area of Focus
Hiv-1 | Infection | Mechanisms | Host Interactions | Rna | Epigenetics | Viral Infections | Immunity | Gene Therapy | Proteins
Jianwei Jiao - University of Chinese Academy of Sciences
Area of Focus
Stem Cells | Regenerative Medicine | Neural Stem Cells | Differentiation | Epigenetics | Brain Development | Transdifferentiation | Neuroscience | Cell Fate | Neurodevelopment
View All
© 2015-2024 Asia Growth Partners Limited | Privacy Policy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.